Price $18.60 |
Market Cap
190.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.96
|
P/S
14.76
|
Dividend %
-
|
|
P/CF
28.5
|
P/FCF
-
|
Op. Cash Flow
-5.7K
|
FCF
-0.6
|
|
Op. Margin
-103.10%
|
Net Margin
-90.30%
|
ROE
-30.20%
|
ROI
-5.10%
|
|
ROA
-11.30%
|
EPS Growth
-40.60%
|
Current Ratio
6.7
|
Debt/Equity
61.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $3.12 | - | - | 785.6M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $3.38 | - | - | 48.8M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $11.57 | - | - | 12.39B | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.62 | - | - | 122M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.90 | - | 0.10% | 1.03B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
